In one paragraphArticle in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Fernando CalzadaUnidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades, 2° Piso CORSE, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Col. Doctores, Mexico City 06725, Mexico.ORCID 0000-0003-1851-5988 Yoseth L RuedafloresUnidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades, 2° Piso CORSE, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Col. Doctores, Mexico City 06725, Mexico.ORCID 0009-0009-0239-9661 Jessica Elena Mendieta-WejebeInstituto Politécnico Nacional, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Plan de San Luis y Salvador Díaz Mirón S/N, Col. Casco de Santo Tomás, Miguel Hidalgo, Mexico City 11340, Mexico.ORCID 0000-0002-2471-9875 Jesica Ramírez-SantosUnidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades, 2° Piso CORSE, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Col. Doctores, Mexico City 06725, Mexico.ORCID 0000-0002-2673-4366 Miguel ValdesUnidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades, 2° Piso CORSE, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Col. Doctores, Mexico City 06725, Mexico.ORCID 0000-0001-7401-303X Claudia VelázquezÁrea Académica de Farmacia, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Circuito exHacienda La Concepción S/N, Carretera Pachuca-Atocpan, San Agustin Tlaxcala 42076, Mexico.ORCID 0000-0003-0546-5969 Elizabeth BarbosaInstituto Politécnico Nacional, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Plan de San Luis y Salvador Díaz Mirón S/N, Col. Casco de Santo Tomás, Miguel Hidalgo, Mexico City 11340, Mexico.ORCID 0000-0002-7111-7922 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AnnonaDiabetes Mellitus, ExperimentalHypoglycemic AgentsPlant ExtractsPlant LeavesPlants, EdiblePlants, MedicinalAnimalsBlood GlucoseFemaleGlucoseGlucose Tolerance TestGlycoside Hydrolase InhibitorsIntestinal AbsorptionMaleMexicoBlood GlucoseGlucoseGlycoside Hydrolase InhibitorsHypoglycemic AgentsPlant ExtractsSodium-Glucose Transporter 1Annona cherimolaantihyperglycemic propertieschirimoya leavesdiabetes mellituspetroleum ether extractSGLT-1 inhibitortoxicityα-glucosidase inhibitor
Identifiers
PMID42123763
PMCPMC13165052
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390